After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...